iPCI 2023
Published: 14 April 2023
-
Views:
5139
-
Likes:
7
-
Views:
5139
-
Likes:
7
-
Up Next
-
1h 5m 38sPart 1 | Session 1 Welcome and Current options for plaque characterisation Joost Daemen, Gijs van Soest, Hector M Garcia-Garcia, Richard A Shlofmitz, Giulio Guagliumi, David Erlinge, Alexander Hirsch
-
44m 3sPart 1 | Session 2 Keynote lecture: Learn IVUS from the Master Ton van der Steen, Gary Mintz
-
1h 10m 30sPart 1 | Session 3 Future options for plaque characterisation: device empowered Ton van der Steen, Brett Bouma, Gijs van Soest, Laura Marcu, Ziad A Ali
-
1h 5m 32sPart 1 | Session 4 Future options for plaque characterisation: computationally empowered Gijs van Soest, Hector M Garcia-Garcia, Shengnan Liu, Shengxian Tu, Frank Gijsen, Jolanda Wentzel
-
49m 22sPart 1 | Session 5 Live case 1 Erasmus University Medical Center, Rotterdam, NL Giulio Guagliumi, Elvin Kedhi, Natalia Pinilla, James Spratt, Evan Shlofmitz
-
1h 7m 21sPart 1 | Session 6 Plaques and drugs Allen Jeremias, Takashi Akasaka, Hector M Garcia-Garcia, David Erlinge, Joost Daemen, Isabella Kardys
-
1h 10m 43sPart 2 | Session 1 Welcome and Lesion significance assessment Joost Daemen, Gijs van Soest, Bon-Kwon Koo, Carlos Collet, Zsolt Piroth, Tim P van de Hoef, Shengxian Tu
-
45m 57sPart 2 | Session 2 Keynote lecture: Why coronary physiology indices differ and what is the clinical relevance? Javier Escaned, Dirk Duncker
-
1h 2m 7sPart 2 | Session 3 Procedural planning Richard A Shlofmitz, Evan Shlofmitz, Allen Jeremias, Carlos Collet, Elvin Kedhi
-
52m 28sPart 2 | Session 4 Imaging for special indications Hiram Bezerra, Ziad A Ali, Niels Ramsing Holm, Natalia Pinilla, James Spratt
-
57m 15sPart 2 | Session 5 Live case 2 Catharina Hospital, Eindhoven, NL Pim Tonino, Joost Daemen, Tim P van de Hoef, Allen Jeremias, Shengxian Tu, Bon-Kwon Koo
Overview
iPCI 2023 was a live two-day event, held on the 13–14 April at the LantarenVenster theatre in Rotterdam, NL. Focusing on image guidance techniques in interventional cardiology, with an educational focus on state-of-the-art imaging and physiology research, iPCI was led by a global faculty of over 35 physicians and engineers.
Led by Course Directors Dr Joost Daemen and Prof Dr Gijs van Soest (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) iPCI aimed to optimise theoretical and practical education to maximise patient outcomes.
iPCI is a successor of Optics in Cardiology, which ran five exciting editions from 2011. For the first time, the dissemination of iPCI sessions extended beyond the venue – a free-to-access live virtual broadcast was open to physicians globally.
Learning Objectives
- Understand invasive plaque characterisation using existing technologies
- Learn about state-of-the-art plaque characterisation using novel technologies and combined imaging modalities
- Get hands-on experience with current IVUS and OCT modalities to recognise different types of plaque
- Learn about the impact of pharmacotherapeutic agents on plaque progression
- Learn how to assess the physiological impact of coronary plaques using the most recent technological developments
- Learn how to do procedural planning using state-of-the-art coronary imaging and physiology tools
- Understand the principles of PCI optimisation using intracoronary imaging and physiology
Target Audience
- Interventional Cardiologists
- Biomedical Imaging Engineers
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Javier Escaned
Head of Interventional Cardiology
Prof Javier Escaned is Head of the Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist in the United Kingdom (Queen Elizabeth University Hospital, Birmingham and Walsgrave Hospital, Coventry) before moving to the Thoraxcenter/Rotterdam (The Netherlands), where he obtained his PhD degree in 1994.
He has authored over 300 scientific articles, books and book chapters on different aspects of interventional cardiology; his latest contribution is Coronary Stenosis. Imaging, Structure and Physiology, a large textbook endorsed by the European Association of Percutaneous Cardiovascular Interventions/European Society of Cardiology (EAPCI/ESC), with its latest edition published in 2015. His main interests in the field of interventional cardiology include intracoronary imaging and physiology, complex percutaneous coronary intervention including chronic total occlusion recanalisation, and acute coronary syndromes.
He…
Bon-Kwon Koo
Professor, Director of Cardiovascular Center and Chair in Cardiology Division
Prof Bon-Kwon Koo is a Professor, Director of Cardiovascular Center and Chair in Cardiology Division at Seoul National University Hospital, Seoul, KR.
His main research interest is imaging and physiology of coronary artery disease.
Prof Koo has published more than 400 papers in major journals. He was a course director of TCT-AP and is a course co-director of ENCORE course.
Ziad A Ali
Dr Ali is a board-certified cardiologist specialising in interventional and structural cardiology at St Francis Hospital and Heart Center in Roslyn, New York.
Ziad is an internationally renowned expert in complex high-risk indicated percutaneous coronary interventions (CHIP) including the treatment of chronic total occlusions (CTO) where the arteries in the heart become completely blocked.
Ziad specialises in the management of cardiovascular disease in patients with pre-existing kidney disease.
Gary Mintz
Senior Medical Advisor
Dr Gary Mintz is a Senior Medical Advisor at the Cardiovascular Research Foundation, New York, US.
Dr Mintz is a pioneer and recognised authority in intravascular imaging and author / co-author of 1,000 peer-reviewed articles or book chapters.
His specialties include interventional cardiology, intravascular imaging and medical education.
Hiram Bezerra
Medical Director
Dr Hiram Bezerra is the Medical Director of the Tampa General Hospital Interventional Cardiology Center of Excellence and a professor at the USF Health Morsani College of Medicine.
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Comments